Nvidia accused of worsening GeForce shortages amid AI chip demand surge. Discover how this impacts gamers and the tech ...

NBA Commissioner Adam Silver said having access to prediction market data can help the league catch insider trading behavior. The comment comes after the NFL filed an amicus brief to the Supreme Court ...

The request comes as Jane Street challenges Sebi’s July 2025 ex parte interim order, which barred the hedge fund from the Indian securities market and directed it to disgorge ₹4,843 crore in alleged ...

For nearly a century, ambitious professionals have turned to books about persuasion for help getting other people to say yes. From Dale Carnegie’s How to Win Friends and Influence People to more ...

GOLDEN, Colo. — A judge sentenced a former forensic analyst for the Colorado Bureau of Investigation to 10 years in prison on Tuesday after authorities said her manipulation of DNA data raised ...

Golden, Colorado (AP) — A judge sentenced a former forensic analyst for the Colorado Bureau of Investigation to 10 years in prison on Tuesday after authorities said her manipulation of DNA data raised ...

Former Colorado Crime Analyst Gets 10-Year Prison Sentence for Manipulating DNA Data GOLDEN, Colo. (AP) — A judge sentenced a former forensic analyst for the Colorado Bureau of Investigation to 10 ...

When regulators at the European Medicines Agency published the full scientific rationale behind Europe's withdrawal of avacopan on August 6, 2026, they put on record something that clinical trial ...

Advanced GIMP photo manipulation tutorials will often dedicate entire sections to these challenges, showing techniques like using the ‘Refine Edge’ dialog (though GIMP’s equivalent might be more ...

Please provide your email address to receive an email when new articles are posted on . Amgen submitted a new trial re-adjudication it says supports avacopan’s noninferiority to placebo in ...

Amgen has submitted a third-party review of avacopan's (Tavneos) pivotal trial data and other analyses to the FDA in a bid to keep the embattled drug for severe anti-neutrophil cytoplasmic ...